Has Nicole Merensztein received payments from drug or device companies?

Yes. Drug and device makers reported $5,004 in general payments to Nicole Merensztein across 203 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicole Merensztein did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicole Merensztein come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicole Merensztein

Physician Assistant · New Hyde Park, NYNPI 1558916163

Payments from drug & device makers

$5,004in general payments, 2019–2025

Across 203 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$744
E.r. Squibb & Sons, L.L.C.$720
Johnson & Johnson$379
AstraZeneca$377
Amgen$362
Novo Nordisk$348
plus $2K from 19 others

What the payments were for

Food & beverage$5,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	32	$744
E.r. Squibb & Sons, L.L.C.	28	$720
Johnson & Johnson	13	$379
AstraZeneca	18	$377
Amgen	15	$362
Novo Nordisk	11	$348
Pfizer	24	$310
Abbott	4	$309
Novartis	13	$246
Scpharmaceuticals Inc.	9	$223
Boston Scientific	4	$200
Lexicon Pharmaceuticals, Inc.	6	$133
Bayer	1	$122
Lilly USA, LLC	3	$77
Esperion Therapeutics, Inc.	3	$72
Kiniksa Pharmaceuticals International, PLC	3	$62
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$59
Bridgebio Pharma, Inc.	3	$58
Boehringer Ingelheim	2	$54
GSK	3	$51
Atricure, Inc.	1	$32
Kiniksa Pharmaceuticals, Ltd.	1	$18
Altathera Pharmaceuticals LLC	1	$17
Heartflow, Inc.	1	$15
Angiodynamics, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,004 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	88	$112,971
EntrestoSacubitril/Valsartan	61	$79,300
XareltoRivaroxaban	40	$41,216
VerquvoVericiguat	20	$26,281
Metoprolol Succinate	125	$1,969
Losartan Potassium	129	$1,388
Atorvastatin Calcium	78	$1,341
Nebivolol Hcl	38	$1,339
Rosuvastatin Calcium	66	$1,113
Amlodipine Besylate	145	$796
Valsartan	17	$632
Diltiazem 24hr Er (Cd)Diltiazem Hcl	11	$609
Carvedilol	46	$467
Ezetimibe	18	$436
Furosemide	69	$410

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$310	$112,97188 claims
NovartisEntresto	$246	$79,30061 claims
Johnson & JohnsonXarelto	$379	$41,21640 claims
MerckVerquvo	$744	$26,28120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in New Hyde Park

Henry YuBronx$1M
Michael AsbachAmherst$962K
Janelle BunceJamestown$565K
Kristyl Cuenca-SiskoNew York$478K
Melissa WhiteGarden City$320K
Lawrence HermanHolbrook$315K
Kaitlyn NelsonBrooklyn$289K
Sari KatzGarden City$271K
Julius NwosuBronx$256K
Cameron KiserNew York$225K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →